Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT02414672 |
Other study ID # |
H-38998 |
Secondary ID |
R01CA187143 |
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
November 2014 |
Est. completion date |
December 2020 |
Study information
Verified date |
April 2024 |
Source |
Baylor College of Medicine |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
The CareSTEPS intervention fills an important service gap by providing education, skills
training, and support to the caregivers of advanced lung cancer patients on active treatment.
The home-based delivery format will facilitate future dissemination and outreach. By
empowering families with the skills they need to provide care and meet the challenges of lung
cancer, this intervention holds great promise for improving caregiver quality of life (QOL),
patient QOL, and the quality of palliative and supportive care services offered to patients
with advanced cancer and their families.
Description:
The profound symptom burden associated with advanced lung cancer (LC) makes caregiving a
complex and burdensome task. Despite the input of outpatient palliative care services, LC
families are often unprepared for caregiving, have low self-efficacy for managing symptoms at
home, report high rates of physical and emotional distress, and receive very little skills
training or psychosocial care. To date, the few psychosocial intervention trials targeting
the caregivers of advanced cancer patients that have been conducted have mostly targeted the
families of hospice patients, have not been well-integrated into routine palliative care, and
have not addressed the specific needs of LC caregivers. Based on our published and recently
completed pilot work in LC, the investigators have developed a psychosocial intervention
called CareSTEPS (self-Care, Stress management, sympTom management, Effective communication,
Problem-solving, and Social support). CareSTEPS is grounded by Self Determination Theory
(SDT) which focuses on individuals' needs for developing autonomy (a sense of choice and
volition), competence (self-efficacy), and relatedness (a sense of belonging and connection).
It: 1) teaches skills to enhance caregiver competence for managing symptoms, practicing
self-care, and coping with cancer; 2) supports caregiver autonomy by providing a clear
rationale for recommendations and a variety of options to encourage choice and elaboration;
and, 3) seeks to improve caregivers' sense of relatedness by teaching strategies for
effective communication and soliciting/accepting social support. 200 LC patients will be
enrolled within one month of treatment initiation (baseline) and their caregivers and
randomize them to either a usual medical care (UMC) condition or the CareSTEPS intervention
(caregivers receive a manual and six 45-minute weekly counseling sessions by telephone). The
primary aim is to determine the impact of the CareSTEPS intervention on caregiver self-care
behaviors, physical and emotional QOL, and satisfaction with care. Secondary aims are to: 1a)
examine the effects of CareSTEPS on the SDT constructs of competence, autonomy, and
relatedness; 1b) test whether caregiver competence, autonomy and relatedness mediate the
effects of CareSTEPS on caregiver outcomes as hypothesized; 2) explore whether
sociodemographic, medical, and relationship factors moderate the effects of the CareSTEPS
intervention on SDT constructs; and, 3) explore the effects of CareSTEPS on patient QOL,
palliative care utilization, and satisfaction with care. CareSTEPS fills an important service
gap by providing education, skills training, and support to the caregivers of advanced LC
patients who are on active treatment. The home-based delivery format will facilitate future
dissemination and outreach. By empowering families with the skills they need to provide care
and meet the challenges of LC, CareSTEPS holds great promise for improving caregiver QOL,
patient QOL, and the quality of palliative/supportive care services for advanced cancer
patients and their families.